E.U. paediatric MOG consortium consensus: Part 5 – Treatment of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders-Reference-Cited by-同舟云学术

E.U. paediatric MOG consortium consensus: Part 5 – Treatment of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders

Published:2020-11 Issue: Volume:29 Page:41-53
ISSN:1090-3798
Container-title:European Journal of Paediatric Neurology
language:en
Short-container-title:European Journal of Paediatric Neurology

Author:

Bruijstens Arlette L.^ORCID,Wendel Eva-Maria,Lechner Christian^ORCID,Bartels Frederik^ORCID,Finke Carsten^ORCID,Breu Markus,Flet-Berliac Lorraine,de Chalus Aliénor,Adamsbaum Catherine,Capobianco Marco,Laetitia Giorgi,Hacohen Yael,Hemingway Cheryl,Wassmer Evangeline,Lim Ming,Baumann Matthias^ORCID,Wickström Ronny,Armangue Thaís,Rostasy Kevin,Deiva Kumaran,Neuteboom Rinze F.^ORCID

Funder

Stichting MS Research

Publisher

Elsevier BV

Subject

Neurology (clinical),General Medicine,Pediatrics, Perinatology and Child Health

Reference81 articles.

1. Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children;Hacohen;Neurol Neuroimmunol Neuroinflamm,2015

2. Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome;Hennes;Neurology,2017

3. Disease course and treatment responses in children with relapsing myelin oligodendrocyte glycoprotein antibody-associated disease;Hacohen;JAMA Neurol,2018

4. The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults;de Mol;Mult. Scler.,2019

5. Anti-myelin oligodendrocyte glycoprotein antibodies in pediatric patients with optic neuritis;Rostasy;Arch. Neurol.,2012

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiological features in pediatric myelin oligodendrocyte glycoprotein antibody-associated disease—diagnostic criteria and lesion dynamics;Pediatric Radiology;2024-09-07

2. Arzneimitteltherapie der mit Myelin-Oligodendrozyten-Glykoprotein-Antikörpern assoziierten Erkrankung (MOGAD);DGNeurologie;2024-08-19

3. Frequency, characteristics, predictors and treatment of relapsing myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD);Multiple Sclerosis and Related Disorders;2024-07

4. FLAIR Hyperintense Cortical Lesions in a 4-Year-Old Child with Myelin Oligodendrocyte Glycoprotein (MOG)-Associated Encephalitis and Seizures: A Case Report;Children;2024-06-27

5. Emergent Management of Central Nervous System Demyelinating Disorders;CONTINUUM: Lifelong Learning in Neurology;2024-06